We are live on
!
Find out more
CPX
Canaan Partners X Portfolio holdings
AUM
$74.7M
1-Year Est. Return
151.56%
This Fund
S&P 500
This Quarter
Est. Return
-17.56%
1 Year Est. Return
+151.56%
3 Year Est. Return
+55.41%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$257M
AUM Growth
-$94.8M
(-27%)
Cap. Flow
-$40.6M
Cap. Flow
% of AUM
-15.83%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASTR
Astra Space, Inc. Class A Common Stock
ASTR
|
+$38.5M |
| 2 |
NextCure
NXTC
|
+$2.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 44.55% |
| 2 | Industrials | 30.67% |
| 3 | Healthcare | 24.79% |
Similar funds
MIC
KCM
SV
TMC
BS
VCM
JAMONY
JCG
Canaan Partners X's Q4 2021 Portfolio in Review
As of Q4 2021, Canaan Partners X held 5 positions worth $257M, down 27% from $351M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Canaan Partners X withdrew a net $40.6M in Q4 2021, closing 1 position and reducing 1 holding. Its most notable exit was NextCure, an estimated $2.17M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 45% of assets, down from 51% a quarter earlier, followed by Industrials and Healthcare.
- Canaan Partners X's biggest Q4 2021 reduction was Astra Space, Inc. Class A Common Stock, cutting an estimated $38.5M.
- Canaan Partners X fully exited NextCure in Q4 2021, selling an estimated $2.17M.
- Canaan Partners X's ten largest holdings make up 100% of its $257M portfolio in Q4 2021.
- Canaan Partners X opened 0 new positions and closed 1 in Q4 2021.
- Canaan Partners X's portfolio value fell 27% quarter-over-quarter to $257M.
Based on Canaan Partners X's 13F filing for Q4 2021, filed 3 Feb 2022.